On (b)(6) 2020, a 25mm amplatzer cribriform occluder was selected for implant in the patient.Bulbous deformation on the left atrial side of the device was noticed upon deployment.The device was re-sheathed and deployed again, yielding the same results.The physician decided to re-sheath and remove the device from the patient.The device was assessed outside of the patient and the clinicians were unable to get the device to reform.The device was exchanged for a 25mm amplatzer pfo occluder, but the device was not suitable to cover the defect and the device was removed.The procedure was abandoned, and will be attempted on a later date.The patient did not experience any adverse events, and is currently discharged.
|
The reported event of a bulbous deployment was confirmed.Following the simulated deployment, the bulbous shape returned to normal and met functional specifications when analyzed at abbott.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all defined manufacturing specifications.A capa was initiated for further investigation and did not identify a product quality issue.However, corrective actions to further enhance performance are being pursued per internal operating procedures.
|